These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 6719658)
1. Calcium oxalate crystal growth in normal urine: role of contraceptive hormones. Tawashi R; Cousineau M; Denis G Urol Res; 1984; 12(1):7-9. PubMed ID: 6719658 [TBL] [Abstract][Full Text] [Related]
2. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
3. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation. Letterie GS Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249 [TBL] [Abstract][Full Text] [Related]
4. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
5. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version. Carlborg L Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925 [TBL] [Abstract][Full Text] [Related]
6. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids. Scott JA; Brenner PF; Kletzky OA; Mishell DR Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817 [TBL] [Abstract][Full Text] [Related]
7. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel. Gaspard UJ; Dubois M; Gillain D; Franchimont P; Duvivier J Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638 [TBL] [Abstract][Full Text] [Related]
8. The effect of contraceptive steroids on hypothalamic-pituitary function. Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765 [TBL] [Abstract][Full Text] [Related]
9. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones. Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ethinylestradiol and mestranol in sequential-type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests. Leis D; Botterman P; Ermler R; Maurer U Fertil Steril; 1977 Jul; 28(7):737-40. PubMed ID: 872954 [TBL] [Abstract][Full Text] [Related]
11. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats. Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875 [TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassay of unconjugated plasma ethynylestradiol in women given a single oral dose of ethynylestradiol or mestranol. de la Pena A; Chenault CB; Goldzieher JW Steroids; 1975 Jun; 25(6):773-80. PubMed ID: 1154455 [TBL] [Abstract][Full Text] [Related]
13. Effect of oral contraceptives on plasma androgenic steroids and their precursors. Fern M; Rose DP; Fern EB Obstet Gynecol; 1978 May; 51(5):541-4. PubMed ID: 148599 [TBL] [Abstract][Full Text] [Related]
14. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Rosenfeld WE; Doose DR; Walker SA; Nayak RK Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594 [TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency. Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796 [TBL] [Abstract][Full Text] [Related]
16. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel. Gaspard UJ; Romus MA; Gillain D; Duvivier J; Demey-Ponsart E; Franchimont P Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622 [TBL] [Abstract][Full Text] [Related]
17. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins. Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183 [TBL] [Abstract][Full Text] [Related]
18. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
19. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
20. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids. Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]